Consolidated Figures in USD Millions.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Total Revenue | - | 1,752.34 | 1,655.26 | 1,518.06 | 1,443.28 |
| Operating Revenue | - | 1,752.34 | 1,655.26 | 1,518.06 | 1,443.28 |
| Cost Of Revenue | - | 955.97 | 938.76 | 828.68 | 812.75 |
| Gross Profit | - | 796.37 | 716.49 | 689.37 | 630.53 |
| Operating Expense | - | 706.84 | 737.04 | 731.31 | 663.48 |
| Research And Development | - | 256.07 | 301 | 304.56 | 279.97 |
| Selling General And Administration | - | 450.76 | 436.04 | 426.75 | 383.51 |
| Total Expenses | - | 1,662.80 | 1,675.80 | 1,559.99 | 1,476.23 |
| Operating Income | - | 89.53 | -20.55 | -41.94 | -32.95 |
| Total Operating Income As Reported | - | 89.53 | -20.55 | -48.05 | -50.47 |
| EBITDA | - | 107.79 | 54.10 | 25.67 | 12.29 |
| Normalized EBITDA | - | 107.79 | 54.10 | 31.78 | 29.80 |
| EBIT | - | 69.28 | 5.13 | -26.71 | -50.03 |
| Interest Income | - | 1.66 | 10.20 | 11.96 | 6.93 |
| Interest Expense | - | 0.55 | 0.73 | 0.44 | 0.46 |
| Net Interest Income | - | 1.10 | 9.47 | 11.52 | 6.47 |
| Other Non Operating Income Expenses | - | -21.90 | 15.47 | 9.37 | -6.50 |
| Other Income Expense | - | -21.90 | 15.47 | 3.26 | -24.01 |
| Interest Income Non Operating | - | 1.66 | 10.20 | 11.96 | 6.93 |
| Interest Expense Non Operating | - | 0.55 | 0.73 | 0.44 | 0.46 |
| Net Non Operating Interest Income Expense | - | 1.10 | 9.47 | 11.52 | 6.47 |
| Pretax Income | - | 68.73 | 4.39 | -27.15 | -50.50 |
| Tax Provision | - | 1.35 | 14.67 | 11 | 10.65 |
| Tax Rate For Calcs | - | 0 | 0 | 0 | 0 |
| Tax Effect Of Unusual Items | - | 0 | 0 | -1.28 | -3.68 |
| Net Income Continuous Operations | - | 67.38 | -10.27 | -38.15 | -61.14 |
| Net Income From Continuing And Discontinued Operation | - | 67.38 | -10.27 | -38.15 | -61.14 |
| Net Income From Continuing Operation Net Minority Interest | - | 67.38 | -10.27 | -38.15 | -61.14 |
| Net Income | - | 67.38 | -10.27 | -38.15 | -61.14 |
| Net Income Common Stockholders | - | 67.38 | -10.27 | -38.15 | -61.14 |
| Net Income Including Noncontrolling Interests | - | 67.38 | -10.27 | -38.15 | -61.14 |
| Normalized Income | - | 67.38 | -10.27 | -33.32 | -47.31 |
| Diluted NI Availto Com Stockholders | - | 67.38 | -10.27 | -38.15 | -61.14 |
| Basic Average Shares | - | 127.69 | 127.70 | 123.22 | 120.75 |
| Diluted Average Shares | - | 137.76 | 127.70 | 123.22 | 120.75 |
| Reconciled Depreciation | - | 38.50 | 48.97 | 52.38 | 62.32 |
| Reconciled Cost Of Revenue | - | 955.97 | 938.76 | 828.68 | 812.75 |
| Total Unusual Items | - | 0 | -9.09 | -6.11 | -17.52 |
| Total Unusual Items Excluding Goodwill | - | 0 | -9.09 | -6.11 | -17.52 |
| Special Income Charges | - | 0 | -9.09 | -6.11 | -17.52 |
| Restructuring And Mergern Acquisition | - | 0 | 9.09 | 6.11 | 17.52 |
| General And Administrative Expense | - | 170.43 | 168.52 | 138.91 | 112.10 |
| Other Gand A | - | 170.43 | 168.52 | 138.91 | 112.10 |
| Selling And Marketing Expense | - | 280.33 | 267.52 | 287.84 | 271.41 |